These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 18586683)
21. Oral anticoagulation and vitamin K deficiency. Eichinger S Hamostaseologie; 2014; 34(3):237-8. PubMed ID: 24919584 [TBL] [Abstract][Full Text] [Related]
22. Statin use decreases coagulation in users of vitamin K antagonists. van Rein N; Biedermann JS; Bonafacio SM; Kruip MJ; van der Meer FJ; Lijfering WM Eur J Clin Pharmacol; 2016 Dec; 72(12):1441-1447. PubMed ID: 27709253 [TBL] [Abstract][Full Text] [Related]
23. Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone. Costedoat-Chalumeau N; Amoura Z; Aymard G; Sevin O; Wechsler B; Cacoub P; Du LT; Diquet B; Ankri A; Piette JC Ann Intern Med; 2000 Apr; 132(8):631-5. PubMed ID: 10766681 [TBL] [Abstract][Full Text] [Related]
25. Effects of vitamin K antagonist phenprocoumon on activated partial thromboplastin time measurement of direct thrombin inhibitors. Fenyvesi T; Jörg I; Weiss C; Harenberg J Blood Coagul Fibrinolysis; 2004 Oct; 15(7):605-11. PubMed ID: 15389129 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation]. Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose. van Schie RM; Verhoef TI; Boejharat SB; Schalekamp T; Wessels JA; le Cessie S; Rosendaal FR; van der Meer FJ; de Boer A; Maitland-van der Zee AH Drug Metabol Drug Interact; 2012; 27(4):229-34. PubMed ID: 23096528 [TBL] [Abstract][Full Text] [Related]
28. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon. Felli A; Zeidler P; Jilma B; Opfermann P; Holaubek C; Zimpfer D; Wadowski PP; Steinlechner B J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):96-101. PubMed ID: 26613641 [TBL] [Abstract][Full Text] [Related]
29. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation. Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350 [TBL] [Abstract][Full Text] [Related]
30. [Derailed oral anticoagulation with very high INR values and poor response to oral vitamin K--cholestasis as a possible cause]. Fontana S; Zeerleder S; Lämmle B Ther Umsch; 1999 Sep; 56(9):477-80. PubMed ID: 10517112 [TBL] [Abstract][Full Text] [Related]
31. The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Erhardtsen E; Nony P; Dechavanne M; Ffrench P; Boissel JP; Hedner U Blood Coagul Fibrinolysis; 1998 Nov; 9(8):741-8. PubMed ID: 9890717 [TBL] [Abstract][Full Text] [Related]
32. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD. Dager WE; White RH Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505 [TBL] [Abstract][Full Text] [Related]
33. Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin. Arpino PA; Demirjian Z; Van Cott EM Pharmacotherapy; 2005 Feb; 25(2):157-64. PubMed ID: 15767231 [TBL] [Abstract][Full Text] [Related]
34. Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing. Gosselin RC; King JH; Janatpur KA; Dager WH; Larkin EC; Owings JT Arch Pathol Lab Med; 2004 Oct; 128(10):1142-5. PubMed ID: 15387708 [TBL] [Abstract][Full Text] [Related]
36. A single dose of oral vitamin K effectively reverses oral anticoagulation with phenprocoumon during heart catheterisation. Ulrich S; Debrunner J; Stoll S; Rentsch K; Bachli EB Swiss Med Wkly; 2006 Oct; 136(43-44):691-5. PubMed ID: 17183431 [TBL] [Abstract][Full Text] [Related]
37. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. Visser LE; Bleumink GS; Trienekens PH; Vulto AG; Hofman A; Stricker BH Br J Haematol; 2004 Oct; 127(1):85-9. PubMed ID: 15384981 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme. Prochaska JH; Coldewey M; Göbel S; Keller K; Hendelmeier M; Konstantinides S; Münzel T; Wild PS; Eur J Prev Cardiol; 2015 May; 22(5):622-8. PubMed ID: 24685605 [TBL] [Abstract][Full Text] [Related]
39. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial. Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676 [TBL] [Abstract][Full Text] [Related]
40. A case series describing the use of argatroban in patients on extracorporeal circulation. Cornell T; Wyrick P; Fleming G; Pasko D; Han Y; Custer J; Haft J; Annich G ASAIO J; 2007; 53(4):460-3. PubMed ID: 17667231 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]